Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs

26th February 2025 Uncategorised 0

Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd brought investors’ attention to the company’s appetite in dealmaking.

More: Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs
Source: fierce